Co-Diagnostics Reports Strong Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Co-Diagnostics (CODX) Tops Q2 EPS by 11c
August 12, 2021 4:03 PM EDTCo-Diagnostics (NASDAQ: CODX) reported Q2 EPS of $0.33, $0.11 better than the analyst estimate of $0.22. Revenue for the quarter came in at $27.4 million versus the consensus estimate of $20.77 million.
GUIDANCE:
Co-Diagnostics sees Q3 2021 EPS of $0.19-$0.22, versus the consensus of $0.18. Co-Diagnostics sees... More
